Manar G. Helal. “Empagliflozin Attenuates Cyclophosphamide-Induced Hepatotoxicity via Targeting Nrf2/HO-1 Signaling, Oxidative Stress, and Inflammation”. World Journal of Pharmaceutical Sciences 7, no. 11 (November 5, 2019): 49–59. Accessed July 22, 2024. https://wjpsonline.com/index.php/wjps/article/view/empagliflozin-attenuates-cyclophosphamide-induced-hepatotoxicity.